Effects of polycyclic aromatic hydrocarbons on liver and lung cytochrome P450s in mice

被引:11
|
作者
Kim, JY
Lee, SK
Kim, CH
Jeon, TW
Moon, CK
Lee, HS
Yoo, SD
Lee, ES
Jeong, TC
机构
[1] Yeungnam Univ, Coll Pharm, Kyungsan 712749, Kyungbuk, South Korea
[2] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
[3] Wonkwang Univ, Coll Pharm, Iksan, South Korea
[4] Sungkyunkwan Univ, Coll Pharm, Suwon, South Korea
关键词
polycyclic aromatic hydrocarbons; cytochrome P450s; induction; liver; lung; mice;
D O I
10.1007/BF02976697
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Certain polycyclic aromatic hydrocarbons (PAHs) have been reported to induce cytochrome P450 (CYP) 1A1 and 1A2. In the present study, the effects of six well-known PAHs, such as benzo[a]pyrene, benz[a]anthracene, dibenz[a,h]anthracene, chrysene, benzo[k]fluorancene and benzo[b]fluorancene, on the activities of hepatic and pulmonary CYP enzymes were investigated in male ICR mice. When mice were treated intraperitoneally with 3, 10 and 30 mg/ kg of individual PAHs for 3 consecutive days, the activities of ethoxyresorufin- and methoxyresorufin-O-dealkylases were significantly and differentially induced in both liver and lung. Moreover, other CYP isozyme-associated monooxygenase activities were also induced significantly in liver and lung with characteristic induction profiles. Our present results suggest that individual PAHs might have inductive effects on CYP isozymes, and that the characteristic inductive effects of individual PAHs on certain CYP isozymes would be developed as a marker for determining exposure to certain PAHs.
引用
收藏
页码:394 / 404
页数:11
相关论文
共 50 条
  • [21] Autoactivation and activation of the cytochrome P450s
    Ekins, S
    Ring, BJ
    Binkley, SN
    Hall, SD
    Wrighton, SA
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (12) : 642 - 651
  • [22] Cytochrome P450s in flavonoid metabolism
    Ayabe S.-I.
    Akashi T.
    Phytochemistry Reviews, 2006, 5 (2-3) : 271 - 282
  • [23] Engineering cytochrome P450s for bioremediation
    Kellner, DG
    Maves, SA
    Sligar, SG
    CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (03) : 274 - 278
  • [24] Novel extrahepatic cytochrome P450s
    Karlgren, M
    Oscarson, M
    Ingelman-Sundberg, M
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 142 - 142
  • [25] The Medicinal Chemistry of the Cytochrome P450s
    Sykes, Matthew
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (18) : 2217 - 2217
  • [26] The ins and outs of cytochrome P450s
    Cojocaru, Vlad
    Winn, Peter J.
    Wade, Rebecca C.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2007, 1770 (03): : 390 - 401
  • [27] Functions of minor cytochrome P450s
    Ingelman-Sundberg, Magnus
    DRUG METABOLISM REVIEWS, 2006, 38 : 4 - 5
  • [28] Interactions of cytochrome P450s with their ligands
    Conner, Kip P.
    Woods, Caleb M.
    Atkins, William M.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 507 (01) : 56 - 65
  • [29] SUBSTRATE RECOGNITION BY CYTOCHROME P450S
    Scott, Emily E.
    Bart, Aaron G.
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S11 - S12
  • [30] Cytochrome P450s and cholesterol homeostasis
    Pikuleva, Irina A.
    PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) : 761 - 773